INVA Q1 2022 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$90M+5.3% YoY

Gross Profit

$90M100.0% margin

Operating Income

$78M86.3% margin

Net Income

$16M17.5% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

-16.4%

Cash Flow

Operating Cash Flow

$98M

Free Cash Flow

$98M

Stock-Based Comp.

$954,000

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$555M

Stockholders' Equity

$387M

Cash & Equivalents

$217M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$90M	$86M	+5.3%
Gross Profit	$90M	$85M	+5.4%
Operating Income	$78M	$79M	-2.2%
Net Income	$16M	$94M	-83.2%

Revenue Segments

Royalty

$29M100%